All In Biotech

Drug Trial Radar · NCT02700815

Capsaicin + Diclofenac Gel in Acute Back Pain or Neck Pain

A Randomized, Controlled Multi-centre Parallel Group Study to Assess the Efficacy and Safety of Multiple Doses of a Topically Applied Combination Containing Diclofenac 2% + Capsaicin 0.075% (2 g Formulation Per Application; 2-times Daily for 5 Days) Compared to Placebo, as Well as to Diclofenac 2% and Capsaicin 0.075% in Patients With Acute Back or Neck Pain

Last checked: Nov 20, 2026Latest source record: May 6, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 746 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

746

Actual

Start

May 9, 2016

Primary completion

Jul 13, 2017

Study completion Jul 21, 2017

Sponsor

Lead sponsor
Boehringer IngelheimBoehringer Ingelheim
Sponsor type
Industry
First posted
Mar 7, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomised, controlled multi-centre parallel group trial will assess the efficacy and tolerability of a topical formulation gel of the combination of diclofenac and capsaicin in comparison to gels with diclofenac alone, capsaicin alone, and placebo for the treatment of acute back pain or neck pain

Conditions

  • Acute Pain

Interventions

  • DiclofenacDrug

  • CapsaicinDrug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in POM Between Baseline and Day 2 Evening, 1 Hour After Drug ApplicationTime frame: Baseline and Day 2

Locations

18 sites in 2 countries. Site status is shown where the registry gives one.

  • emovis GMBH, Berlin

    Berlin, Germany

  • Synexus Clinical Research GmbH

    Berlin, Germany

  • Synexus Clinical Research GmbH

    Bochum, Germany

  • Sport- und Präventionsmedizinische Praxis, 50933 Köln

    Cologne, Germany

  • Dünnwaldpraxis, Köln

    Cologne, Germany

  • Praxis Dr. Steinebach, Essen

    Essen, Germany

  • Praxis Dr. Schaefer, 45355 Essen

    Essen, Germany

  • Unterfrintroper Hausarztzentrum

    Essen, Germany

  • Synexus Clinical Research GmbH

    Frankfurt, Germany

  • Praxis Dr. Pabst, Gilching

    Gilching, Germany

  • Praxis Dr. Dahmen, 22415 Hamburg

    Hamburg, Germany

  • Praxis Dr. Klein, Künzing

    Künzing, Germany

  • Synexus Clinical Research GmbH

    Leipzig, Germany

  • Anästhesiologie Rheinbach

    Rheinbach, Germany

  • University Clinic of Headache, Private Practice, Moscow

    Moscow, Russia

  • State Budget.Hlthcare Inst.City Outpatient dept #123,Therapy

    Saint Petersburg, Russia

  • Medical Centre "Reavita", Therapy Dept., St. Petersburg

    Saint Petersburg, Russia

  • St.Petersburg State Budget.Hlthcare Inst.City Outpat.dep#107

    Saint Petersburg, Russia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.